Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Operating Leases (2021 - 2023)

Historic Operating Leases for Dna X (SONM) over the last 3 years, with Q4 2023 value amounting to $55000.0.

  • Dna X's Operating Leases fell 1666.67% to $55000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $55000.0, marking a year-over-year decrease of 1666.67%. This contributed to the annual value of $55000.0 for FY2023, which is 1666.67% down from last year.
  • Latest data reveals that Dna X reported Operating Leases of $55000.0 as of Q4 2023, which was down 1666.67% from $120000.0 recorded in Q3 2023.
  • In the past 5 years, Dna X's Operating Leases ranged from a high of $1.6 million in Q2 2022 and a low of $55000.0 during Q4 2023
  • In the last 3 years, Dna X's Operating Leases had a median value of $183000.0 in 2023 and averaged $392555.6.
  • Per our database at Business Quant, Dna X's Operating Leases changed by 0.0% in 2022 and then crashed by 8836.62% in 2023.
  • Over the past 3 years, Dna X's Operating Leases (Quarter) stood at $66000.0 in 2021, then changed by 0.0% to $66000.0 in 2022, then dropped by 16.67% to $55000.0 in 2023.
  • Its Operating Leases was $55000.0 in Q4 2023, compared to $120000.0 in Q3 2023 and $183000.0 in Q2 2023.